Related references
Note: Only part of the references are listed.MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells
Li Yin et al.
BLOOD (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
V. W. Y. Lui et al.
ONCOGENE (2011)
被撤回的出版物: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development (Retracted article. See vol. 40, pg. 1442, 2022)
Flavia Pichiorri et al.
CANCER CELL (2010)
Survival of Human Multiple Myeloma Cells Is Dependent on MUC1 C-Terminal Transmembrane Subunit Oncoprotein Function
Li Yin et al.
MOLECULAR PHARMACOLOGY (2010)
Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
Koh Furugaki et al.
ONCOLOGY REPORTS (2010)
Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells
Deepak Raina et al.
CANCER RESEARCH (2009)
HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
Rajesh R. Nair et al.
MOLECULAR CANCER THERAPEUTICS (2009)
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Maya Datt Joshi et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
Rentian Feng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The MUC1 and galectin-3 oncoproteins function in a MicroRNA-dependent regulatory loop
Selvi Ramasamy et al.
MOLECULAR CELL (2007)
Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62
Yumei Leng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mucin 1 oncoprotein blocks hypoxia-inducible factor 1α activation in a survival response to hypoxia
Li Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling
Jian Ren et al.
MOLECULAR CANCER RESEARCH (2006)
Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma
Silvie Cloosen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
MUC1 oncoprotein blocks glycogen synthase kinase 3β-mediated phosphorylation and degradation of β-catenin
L Huang et al.
CANCER RESEARCH (2005)
Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species
L Karawajew et al.
BLOOD (2005)
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
J Ren et al.
CANCER CELL (2004)
被撤回的出版物: Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis (Retracted article. See JAN, 2023)
A Fico et al.
CELL DEATH AND DIFFERENTIATION (2004)
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors
XY Pei et al.
CLINICAL CANCER RESEARCH (2004)
MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress
L Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress
L Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human DF3/MUC1 carcinoma-associated protein functions as an oncogene
YQ Li et al.
ONCOGENE (2003)
Arsenic trioxide-induced apoptosis in myeloma cells:: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL
Q Liu et al.
BLOOD (2003)
DF3/MUC1 signaling in multiple myeloma cells is regulated by intarleukin-7
Y Li et al.
CANCER BIOLOGY & THERAPY (2003)
Mitochondria: Regulators of signal transduction by reactive oxygen and nitrogen species
PS Brookes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells
T Otsuki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
